Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA; Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA; Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA.
Department of Hematology and Oncology, Okayama University Hospital, Okayama 700-8558, Japan.
Stem Cell Reports. 2022 Jul 12;17(7):1509-1535. doi: 10.1016/j.stemcr.2022.06.004.
In this retrospective, we review the two research topics that formed the basis of the outstanding career of Dr. Paul S. Frenette. In the first part, we focus on sickle cell disease (SCD). The defining feature of SCD is polymerization of the deoxygenated mutant hemoglobin, which leads to a vicious cycle of hemolysis and vaso-occlusion. We survey important discoveries in SCD pathophysiology that have led to recent advances in treatment of SCD. The second part focuses on the hematopoietic stem cell (HSC) niche, the complex microenvironment within the bone marrow that controls HSC function and homeostasis. We detail the cells that constitute this niche, and the factors that these cells use to exert control over hematopoiesis. Here, we trace the scientific paths of Dr. Frenette, highlight key aspects of his research, and identify his most important scientific contributions in both fields.
在本次回顾中,我们将探讨构成保罗·S·弗里尼特博士杰出职业生涯基础的两个研究课题。在第一部分中,我们重点关注镰状细胞病(SCD)。SCD 的特征是去氧突变血红蛋白的聚合,导致溶血和血管阻塞的恶性循环。我们调查了 SCD 病理生理学中的重要发现,这些发现为 SCD 的治疗带来了新的进展。第二部分重点介绍造血干细胞(HSC)龛,这是骨髓内控制 HSC 功能和内稳态的复杂微环境。我们详细介绍了构成这个龛的细胞,以及这些细胞用来控制造血的因素。在这里,我们追溯了弗里尼特博士的科学路径,突出了他研究的关键方面,并确定了他在这两个领域的最重要的科学贡献。